Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies targeting RNA deregulation.
190A | T
Overview
Corporate Details
- ISIN(s):
- JP3283730004
- LEI:
- Country:
- Japan
- Address:
- 藤沢市村岡東２−２６−１
Description
Chordia Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the research and development of novel cancer therapies. The company focuses on discovering and developing first-in-class, small-molecule drugs that target RNA deregulation, a key driver in various cancers. Its mission is to create life-changing treatments for patients by advancing a pipeline of innovative drug candidates from preclinical research through clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-10 08:00 |
有価証券届出書（新規公開時）
|
Japanese | ZIP • 5.7 MB |
Automate Your Workflow. Get a real-time feed of all Chordia Therapeutics,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Chordia Therapeutics,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chordia Therapeutics,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
